23andMe facing class action suit for making ‘genetic predictions’

Image via Vice

It’s been a rough couple of weeks for 23andMe. First, the federal Food and Drug Administration ordered the company to immediately halt sales of its flagship $99 at-home DNA tests. Now, in the midst of that regulatory maelstrom, 23andMe is being hit with a class-action lawsuit alleging that the firm misled consumers with advertising for its personalized genome services.

At issue is the fact that 23andMe is not simply a fun way for people to play with genetics. 23andMe and other similar consumer genetics companies have moved towards marketing their services as a way to predict, and perhaps prevent, future health problems. It’s 23andMe’s claims that its interpretations of users’ genomic data can provide health benefits, and not the genetic data itself, that’s the concern.

Read the full, original story here: DNA Testing Is Not Why 23andMe Is in Trouble

Additional Resources:


Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend